Leiomyosarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2019-05-13
Clinical Trial Update: Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin [Phase 3]
A Phase 3 trial studying trabectedin for leiomyosarcoma, liposarcoma, and synovial sarcoma was withdrawn.